Search CROs

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services
• Clinical Imaging Core Lab

Specialized cardiovascular CRO offering full-spectrum clinical development from protocol design through regulatory submission, with deep cardiology expertise and core laboratory services across all development phases.

• Analytical Method Development & Validation
• ICH Stability Studies

ISO 17025:2017 and ISO/IEC 17023:2017 accredited Canadian analytical laboratory providing regulatory-compliant testing for pharmaceuticals, natural health products, botanicals, food and beverage, cosmetics, and cannabis across method development, stability studies, and quality control.

CRAMSN is a contract research, development, and manufacturing organization (CRO/CDMO/CMO) offering end-to-end solutions for drug substance and drug product development with GMP-certified facilities recognized by US, EU, Japan, and Canada regulatory authorities.

• Bioanalysis
• Carcinogenicity Studies
• Flow Cytometry Services

Midsize preclinical CRO specializing in GLP-compliant toxicology, IND-enabling safety studies, infectious disease vaccine development, and inhalation toxicology with onsite integrated laboratories and 60+ years of regulatory partnership experience.

• Device & Combination Product Services
• Biologics (Other)
• Small Molecule

Global CDMO with 8,000+ employees across 38 GMP facilities offering sterile and non-sterile development, manufacturing, fill-finish, lyophilization, prefilled syringes, drug-device combinations, cold chain packaging, and clinical trial services.

• Analytical Method Development & Validation
• China NMPA Regulatory Strategy
• EU EMA Regulatory Strategy

uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

• Clinical Operations
• Phase II Clinical Trials
• Phase III Clinical Trials

Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

• In Vivo Efficacy Models
• In Vivo PK / PD Studies
• Preclinical In Vivo Studies

Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.

• Analytical Method Development & Validation
• Small Molecule

ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.

• Antibody-Drug Conjugate (ADC)
• Biologics (Other)
• Small Molecule

Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.

• Analytical Method Development & Validation
• ICH Stability Studies
• Biologics (Monoclonal Antibodies)

Global cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Clinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually.

• AAV / Viral Vector Platform
• Biologics (Monoclonal Antibodies)
• Biologics (Other)

Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

ethica CRO is the first contract research organization in the world to achieve HRPP accreditation from three distinct accrediting bodies, specializing in medical aesthetics, dermatology, and clinical trial management with a focus on ethical excellence and participant safety.

• Antibody-Drug Conjugate (ADC)
• Biologics (Monoclonal Antibodies)
• Biologics (Other)

Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale.